Black Diamond Therapeutics, Inc. (BDTX)

BDTX Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	26.24	57.04	35.48	67.02	35.83	154.72
Short-Term Investments	89.78	75.18	88.49	143.99	280.46	0
Cash & Cash Equivalents	116.02	132.22	123.98	211.01	316.29	154.72
Cash Growth	10.99%	6.65%	-41.25%	-33.29%	104.43%	199.50%
Other Current Assets	2.79	1.81	3.73	4.69	3.26	0.99
Total Current Assets	118.81	134.03	127.71	215.7	319.55	155.71
Property, Plant & Equipment	22.9	23.71	27.38	30.74	8.79	0.16
Other Long-Term Assets	0.82	0.82	1.17	1.24	1.33	2.42
Total Long-Term Assets	23.72	24.53	28.55	31.98	10.12	2.58
Total Assets	142.52	158.57	156.26	247.68	329.67	158.3
Accounts Payable	1.18	2.32	1.88	4.11	2.54	1.96
Other Current Liabilities	15.68	17.32	13.38	19.54	11.68	2.9
Total Current Liabilities	16.85	19.65	15.26	23.64	14.22	4.86
Long-Term Debt	21.36	22.19	25.3	28.14	7.69	0
Other Long-Term Liabilities	0	0	0	0	0	0.02
Total Long-Term Liabilities	21.36	22.19	25.3	28.14	7.69	0.02
Total Liabilities	38.22	41.83	40.56	51.78	21.91	4.88
Total Debt	21.36	22.19	25.3	28.14	7.69	0
Debt Growth	-12.97%	-12.31%	-10.10%	265.74%	-	-
Retained Earnings	-435.66	-417.43	-334.99	-243.82	-118.22	-50.97
Comprehensive Income	-0.1	-0.03	-1.82	-0.41	0.61	0
Shareholders' Equity	104.31	116.74	115.7	195.9	307.76	-47.16
Net Cash / Debt	94.66	110.04	98.68	182.87	308.6	154.72
Net Cash / Debt Growth	18.34%	11.51%	-46.04%	-40.74%	99.45%	199.50%
Net Cash Per Share	1.83	2.50	2.72	5.05	9.38	74.54
Working Capital	101.95	114.39	112.45	192.06	305.34	150.85
Book Value Per Share	2.01	2.66	3.19	5.41	9.35	-22.72

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).